Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3974224rdf:typepubmed:Citationlld:pubmed
pubmed-article:3974224lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:3974224lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:3974224lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:3974224lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:3974224lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:3974224lifeskim:mentionsumls-concept:C0045043lld:lifeskim
pubmed-article:3974224lifeskim:mentionsumls-concept:C0623842lld:lifeskim
pubmed-article:3974224pubmed:issue1lld:pubmed
pubmed-article:3974224pubmed:dateCreated1985-4-12lld:pubmed
pubmed-article:3974224pubmed:abstractTextThe isolation of 18-hydroxycortisol from the urine of patients with primary aldosteronism was recently described and no synthetic procedure was available for its preparation. The C-13 angular methyl group of prednisolone-17 alpha,21-acetonide-11 beta-nitrite was functionalized by photolysis in the presence of oxygen to give the product 18-hydroxy-prednisolone-17 alpha,21-acetonide-18-nitrate. The 18-nitrate was reduced with zinc and ammonium acetate to the corresponding 18-hydroxy compound, 18-hydroxy-prednisolone-17 alpha,21-acetonide. Homogeneous hydrogenation with Tris(triphenyl-phosphine)rhodium (I) chloride as catalyst resulted in the formation of 18-hydroxy-cortisol-17 alpha,21-acetonide. Acid hydrolysis of the latter compound gave 18-hydroxycortisol. Oxidation of 18-hydroxycortisol-17 alpha,21-acetonide with pyridinium dichromate followed by acid hydrolysis gave 18-hydroxycortisone. The 18-hydroxylated steroids exist as the 18,21-hemiacetals. Catalytic reduction with tritium gas with Tris(triphenyl-phosphine)rhodium (I) chloride of 18-hydroxyprednisolone-17 alpha,21-acetonide and acid hydrolysis gave [1,2(3)H]18-hydroxycortisol.lld:pubmed
pubmed-article:3974224pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:languageenglld:pubmed
pubmed-article:3974224pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:citationSubsetIMlld:pubmed
pubmed-article:3974224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3974224pubmed:statusMEDLINElld:pubmed
pubmed-article:3974224pubmed:monthJanlld:pubmed
pubmed-article:3974224pubmed:issn0022-4731lld:pubmed
pubmed-article:3974224pubmed:authorpubmed-author:KerrH WHWlld:pubmed
pubmed-article:3974224pubmed:authorpubmed-author:MilewichLLlld:pubmed
pubmed-article:3974224pubmed:authorpubmed-author:Gomez-Sanchez...lld:pubmed
pubmed-article:3974224pubmed:authorpubmed-author:FarrantR DRDlld:pubmed
pubmed-article:3974224pubmed:issnTypePrintlld:pubmed
pubmed-article:3974224pubmed:volume22lld:pubmed
pubmed-article:3974224pubmed:ownerNLMlld:pubmed
pubmed-article:3974224pubmed:authorsCompleteYlld:pubmed
pubmed-article:3974224pubmed:pagination141-6lld:pubmed
pubmed-article:3974224pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:meshHeadingpubmed-meshheading:3974224-...lld:pubmed
pubmed-article:3974224pubmed:year1985lld:pubmed
pubmed-article:3974224pubmed:articleTitle18-Substituted steroids: synthesis of 18-hydroxycortisol (11 beta,17 alpha,18,21-tetrahydroxy-4-pregnene-3,20-dione) and 18-hydroxycortisone (17 alpha,18,21-trihydroxy-4-pregnene-3,11,20-trione).lld:pubmed
pubmed-article:3974224pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3974224pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3974224pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed